Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
Gregory W. Albers,Rüdiger von Kummer,Thomas Truelsen,Jens-Kristian Slott Jensen,Gabriela Martinez Ravn,Bjørn Grønning,Hugues Chabriat,Ku‐Chou Chang,Antonio Dávalos,Gary A. Ford,James C. Grotta,Markku Kaste,Lee H. Schwamm,Ashfaq Shuaib